Chaurand-Lara, Jorge <br/><br/>
Incidence of osteonecrosis of the jaw by the use of osteoclast inhibitors in patients with bone metastases: a retrospective cohort study.  [electronic resource] 

 -  Cirugia y cirujanos  2019 
 - 396-401 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2444-054X 
<br/><br/><label>Standard No.: </label>10.24875/CIRU.18000661  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alendronate--adverse effects<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--epidemiology<br/>Bone Density Conservation Agents--adverse effects<br/>Bone Neoplasms--drug therapy<br/>Denosumab--adverse effects<br/>Diphosphonates--adverse effects<br/>Female<br/>Humans<br/>Incidence<br/>Male<br/>Mexico--epidemiology<br/>Middle Aged<br/>Osteoclasts--drug effects<br/>Retrospective Studies<br/>Risedronic Acid--adverse effects<br/>Time Factors<br/>Zoledronic Acid--adverse effects